Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mosaic deletion of claudin-5 reveals rapid non-cell-autonomous consequences of blood-brain barrier leakage
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Vascular Biology.ORCID iD: 0000-0002-7911-6174
Karolinska Inst, Single Cell Core Facil Flemingsberg Campus SICOF, S-14157 Huddinge, Sweden..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Vascular Biology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Cancer Immunotherapy.ORCID iD: 0000-0001-7092-8099
Show others and affiliations
2024 (English)In: Cell Reports, E-ISSN 2211-1247, Vol. 43, no 3, article id 113911Article in journal (Refereed) Published
Abstract [en]

Claudin-5 (CLDN5) is an endothelial tight junction protein essential for blood-brain barrier (BBB) formation. Abnormal CLDN5 expression is common in brain disease, and knockdown of Cldn5 at the BBB has been proposed to facilitate drug delivery to the brain. To study the consequences of CLDN5 loss in the mature brain, we induced mosaic endothelial-specific Cldn5 gene ablation in adult mice (Cldn5iECKO). These mice displayed increased BBB permeability to tracers up to 10 kDa in size from 6 days post induction (dpi) and ensuing lethality from 10 dpi. Single-cell RNA sequencing at 11 dpi revealed profound transcriptomic differences in brain endothelial cells regardless of their Cldn5 status in mosaic mice, suggesting major non-cell-autonomous responses. Reactive microglia and astrocytes suggested rapid cellular responses to BBB leakage. Our study demonstrates a critical role for CLDN5 in the adult BBB and provides molecular insight into the consequences and risks associated with CLDN5 inhibition.

Place, publisher, year, edition, pages
Elsevier, 2024. Vol. 43, no 3, article id 113911
National Category
Cell and Molecular Biology
Identifiers
URN: urn:nbn:se:uu:diva-527246DOI: 10.1016/j.celrep.2024.113911ISI: 001204344300001PubMedID: 38446668OAI: oai:DiVA.org:uu-527246DiVA, id: diva2:1854761
Part of project
Vascular growth and permeability in health and disease, Swedish Research Council
Funder
Swedish Research Council, 2023-02655Swedish Research Council, 2015-00550Swedish Research Council, 2021-04896EU, European Research Council, AdG294556Swedish Cancer Society, 150735Knut and Alice Wallenberg Foundation, 2015.0030Knut and Alice Wallenberg Foundation, 2020.0057EU, European Research Council, 864522European Regional Development Fund (ERDF)Available from: 2024-04-26 Created: 2024-04-26 Last updated: 2025-05-13Bibliographically approved
In thesis
1. Studies on the Brain Vasculature: Blood-Brain Barrier Permeability and Brain Inflammation
Open this publication in new window or tab >>Studies on the Brain Vasculature: Blood-Brain Barrier Permeability and Brain Inflammation
2025 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

The blood-brain barrier (BBB) is a specialized vascular interface that protects the central nervous system (CNS) by tightly regulating molecular exchange between the blood and brain parenchyma. Despite its importance, the mechanisms underlying BBB development, maintenance, and dysfunction remain incompletely understood. In this thesis, we investigated the effects of Angiopoietin 2 (ANGPT2) deficiency during development and Claudin 5 (CLDN5) loss in adulthood on BBB integrity, developed a refined method for isolating brain vascular cells, and performed cross-species transcriptomic comparisons to identify gene expression similarities and differences between mouse and human brain pericytes.

Our results show that constitutive Angpt2 knockout leads to spatially localized vascular malformations in the adult brain, particularly in the basal ganglia and somatosensory cortex, accompanied by increased permeability, angiogenesis, mural cell alterations, ECM accumulation, and glial reactivity. Single-cell RNA sequencing identified a distinct endothelial population in Angpt2 knockout mice enriched for genes involved in angiogenesis and matrix remodeling. In contrast, inducible, endothelial-specific deletion of Cldn5 in adult mice caused size-selective BBB leakage, neuroinflammation, and widespread transcriptional changes in both CLDN5-positive and -negative endothelial cells, indicating indirect effects. Additionally, to facilitate high-quality single-cell analysis, we developed a magnetic bead-based protocol for isolating brain microvascular fragments, which enriched for vascular and perivascular cell types while preserving mRNA and protein integrity. Finally, we compared gene expression profiles of mouse and human brain pericytes using public datasets, revealing species-specific transcriptional differences.

Together, these studies provide new insights into the molecular regulation of the BBB in both developmental and mature contexts. By integrating genetic models, imaging, single-cell technologies, and cross-species analysis, our work advances understanding of neurovascular biology and offers valuable tools and knowledge to enhance the translational relevance of preclinical models in neurological research.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2025. p. 51
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 2164
Keywords
Blood-brain barrier, Angiopoietin 2, Claudin 5, Single-cell RNA sequencing
National Category
Basic Medicine
Research subject
Medical Science
Identifiers
urn:nbn:se:uu:diva-556469 (URN)978-91-513-2510-1 (ISBN)
Public defence
2025-09-03, Rudbecksalen, Rudbeck Laboratory, Dag Hammarskjölds väg 20, Uppsala, 10:00 (English)
Opponent
Supervisors
Available from: 2025-06-11 Created: 2025-05-13 Last updated: 2025-06-11

Open Access in DiVA

fulltext(12120 kB)304 downloads
File information
File name FULLTEXT01.pdfFile size 12120 kBChecksum SHA-512
a97dac7c8bcaeed4a77e709c53d39bdc4fd3239ccfaf93ca55d410b7100238123d86d74bdf0bda2441ab109489e9c7f026497b4e6c71bb915bc403ecd82447b8
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Vázquez-Liébanas, ElisaLi, WeihanLaviña, BàrbaraElbeck, ZaherNikoloudis, IoannisGängel, KonstantinVanlandewijck, MichaelBetsholtz, ChristerAndaloussi Mäe, Maarja

Search in DiVA

By author/editor
Vázquez-Liébanas, ElisaLi, WeihanLaviña, BàrbaraElbeck, ZaherNikoloudis, IoannisGängel, KonstantinVanlandewijck, MichaelBetsholtz, ChristerAndaloussi Mäe, Maarja
By organisation
Vascular BiologyCancer Immunotherapy
In the same journal
Cell Reports
Cell and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 304 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 674 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf